GlycoMimetics, Inc. (NASDAQ: GLYC) today announced the publication of a paper in Nature Cell Biology that describes how tumor cells engage specific stromal components, most notably E-selectin, for propagation and outgrowth.1 The paper provides further scientific support for the clinical trial in breast cancer patients with bone metastasis that was recently announced by GlycoMimetics.
{iframe}https://ir.glycomimetics.com/news-releases/news-release-details/glycomimetics-announces-publication-nature-cell-biology-paper{/iframe}